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Although the pathogenic effects of a primary cytomegalovirus (CMV) infection on hematopoiesis has been largely
investigated so far, the effects of a persistent or latent infection have yet to be elucidated. The effects of persistent CMV
infection on hematopoiesis thus were examined using BALB/c mice at 4 weeks postinfection with 0.2 LD50 of murine CMV
(MCMV) infection as a persistent infection model. The parameters of constitutive hematopoiesis of MCMV persistently
infected mice were completely identical to those of the control. However, the inductive hematopoiesis, examined by the
autologous marrow reconstitution after 5-fluorouracil administration, was significantly impaired in the MCMV persistently
infected mice (P , 0.05). In a colony-forming unit-spleen assay and a long-term bone marrow culture system, a decreased
capacity of bone marrow stromal cells to support hematopoiesis was observed in the MCMV-infected mice in comparison
with the controls. The existence of MCMV DNA in the adherent cells of long-term bone marrow culture from the
MCMV-infected mice were confirmed by a polymerase chain reaction but not in the nonadherent cells. Furthermore, the
increased expression level of tumor necrosis factor-a by stromal cells was also observed by semiquantitative reverse
transcriptase-polymerase chain reaction. These results therefore strongly suggest that MCMV remains to infect the stromal
cells while also inhibiting inductive hematopoiesis through the impairment of the stromal cell functions in the MCMV
persistently infected mice. © 1999 Academic Press
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Cytomegaloviruses (CMVs) are ubiquitous members
f the herpes viruses that commonly infect various ani-
als including humans. Similar to other herpesviruses,
he establishment of latency and persistence after a
rimary infection is the hallmark of CMV infection (Britt et
l., 1996). A primary or recurrent human CMV (HCMV)
nfection is a major cause of significant morbidity and
ortality rates in immunocompromised patients, espe-
ially in recipients of bone marrow (BM) and solid organ
ransplantation (Lewis et al., 1988; Myers et al., 1986) and
cquired immune deficiency syndrome patients (Jacob-
on et al., 1988). In addition to pneumonia, gastroenteric
iseases, and retinitis, HCMV has been reported to
ause delayed marrow engraftment and even graft fail-
re after BM transplantation (BMT) (Apperley et al., 1988;
ilgrami et al., 1994; Verdonck et al., 1985). Furthermore,
M suppression with leukocytopenia is one of the most
ommon features of the HCMV infection, especially in
ewborn infants and immunocompromised hosts (Peter-
on et al., 1980; Yeager et al., 1982). In vitro studies have
ndicated both a direct inhibitory effect of HCMV on the
1 To whom reprint requests should be addressed. Fax: 81-463-92-
i511. E-mail: andok@keyaki.cc.u-tokai.ac.jp.
145roliferation and differentiation of hematopoietic progen-
tor cells (HPCs) (Collier et al., 1989; Maciejewski et al.,
992; Sing et al., 1990) and an alteration of the stromal
ells in the hematopoietic microenvironment (ME) (Ap-
erley et al., 1989; Lagneauxet al., 1994; Simmons et al.,
990).
Because of a strict species specificity of CMV and
imilarities in the genomic organization and pathological
onditions with HCMV, murine CMV (MCMV) have been
sed as an animal model to study lethal CMV diseases,
rotection against it, and the conditions of persistent and
atent infections and reactivation in vivo (Hudson 1979).
egarding hematopoiesis, we and other investigators
reviously reported on the in vivo myelosuppressive ef-
ects of primary MCMV infection in both immunocompe-
ent and immunocompromised hosts (Gibbons et al.,
995; Mori et al., 1997; Mutter et al., 1988).
Although clinical complications related to HCMV infec-
ion in immunocompromised patients can result from a
rimary infection, most such complications result from
ither a persistent infection or recurrence from latency in
he tissues of the patients or the transplanted organs
Myers et al., 1986). In contrast to the large body of
xperimental data in primary infection, very little is still
nown about the hematopoiesis in the hosts persistentlynfected with CMV. We therefore used an animal model of
0042-6822/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.
p
n
(
e
I
M
a
d
(
t
s
(
(
p
P
M
(
r
s
1
t
r
i
t
c
M
1
h
w
t
P
i
c
t
k
b
b
a
T
t
w
f
a
A
i
c
(
n
H
m
i
m
C
M
i
f
r
a
a
n
m
r
146 MORI ET AL.ersistent MCMV infection, where viral replication was
ot observed in any organs except for the salivary glands
Matsuzawa et al., 1995; Yuhasz et al., 1994) and thus
xamined whether any defects of hematopoiesis existed.
n the present study in mice persistently infected with
CMV, we observed (1) the normal number of function-
lly and phenotypically defined HPCs in the BM, (2) the
elayed autologous BM reconstitution after 5-fluorouracil
5-FU) administration, (3) the impaired stromal cell func-
ions in both the colony-forming unit-spleen (CFU-S) as-
ay and the long-term BM culture (LTBMC) system, and
4) the increased expression of tumor necrosis factor-a
TNF-a) in the adherent cell fractions in LTBMC com-
ared with normal mice.
RESULTS
eripheral blood cell counts and BM cellularity in
CMV persistently infected mice
In the present study, mice at 4 weeks postinfection
p.i.) with 1 3 105 PFU (0.2 LD50) of MCMV, where no viral
eplication was detected in any organs except in the
alivary glands (Matsuzawa et al., 1995; Yuhasz et al.,
994), were used as the model of persistent CMV infec-
ion. As the parameters of hematopoiesis, both the pe-
ipheral blood cell counts and BM cellularity were exam-
ned. As we and other investigators have reported, a
ransient decrease in the number of peripheral blood
ells and BM cells is observed in the acute phase of
CMV infection (Gibbons et al., 1994, 1995; Mori et al.,
997; Mutter et al., 1988). However, the total leukocyte,
ematocrit, platelet count, and number of BM cells 4
eeks p.i. were all almost identical to those of the con-
rol mice (Table 1).
opulation of the HPCs in the MCMV persistently
nfected mice
To enumerate the HPCs in BM, we performed a flow
ytometry and in vitro colony assay. We first examined
he populations of Lin2-c-kit-Sca-1-positive (Lin2c-
T
Peripheral Blood Cells, BM Cellularity, and Lin2c-kit1Sc
Leukocyte
(/ml)
Hematocrit
(%)
ontrol 3197 6 305 53.7 6 5.0
CMV 4 weeks p.i. 3400 6 435 53.4 6 1.8
Note. Peripheral blood cell counts, BM cellularity, and number of Lin
nfected with MCMV (4 weeks p.i.) were examined (n 5 5). Perpheral bl
emurs and tibias, counted, and stained with antilineage markers, c-kit
epresents the mean 6 S.E.M.it1Sca-11) cells, which have recently been shown to ne primitive HPCs (Okada et al., 1992). The total num-
er of Lin2c-kit1Sca-11 cells in both the control mice
nd MCMV persistently infected mice are shown in
able 1. No significant differences were observed in
he mice 4 weeks p.i. Second, an in vitro colony assay
as performed to assess the number of colony-
orming unit-granulocytes/macrophages (CFU-GM)
nd burst-forming unit-erythroid (BFU-E) in BM cells.
s a result, no significant differences were observed
n the number of both CFU-GM and BFU-E between the
ontrol mice and the MCMV persistently infected mice
Fig. 1). These results thus definitely prove that the
umber of phenotypically and functionally defined
PCs in the BM of the MCMV persistently infected
ice was identical to that of the control mice. Because
t was confirmed that constitutive hematopoiesis is
aintained in the MCMV persistently infected mice,
ells in the Control Mice and the MCMV-Infected Mice
latelet count
(3104/ml)
BM cellularity
(3107)
Total number of
Lin2c-kit1Sca-11 cells
(3104)
68.9 6 3.6 3.72 6 0.24 2.24 6 0.48
65.6 6 7.2 3.95 6 0.35 1.98 6 0.69
Sca-11 cells in the BM of the control mice and the mice persistently
s obtained by intracardiac puncture. BM cells were obtained from the
ca-1 antibodies for flow cytometry analysis. The number in the figure
FIG. 1. In vitro colony assay. BM cells were obtained from the femurs
nd tibias of BALB/c mice 4 weeks p.i. with 0.2 LD50 of MCMV. CFU-GM
nd BFU-E assay was carried out in a methylcellulose culture (p). The
umber of colonies was assessed after 14 days of culture. Uninfected
ice were used as the control mice (u). The number in the figure
epresents the number of colonies per 1 3 105 BM cells (mean 6 SEM,ABLE 1
a-11 C
P
2c-kit1
ood wa
, and S5 4). N.S. indicates not significant.
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147BONE MARROW DYSFUNCTION IN MCMV INFECTIONe examined the effects of persistent MCMV infection
n inductive hematopoiesis.
ffects of persistent MCMV infection on the BM
ecovery after 5-FU treatment
To examine inductive hematopoiesis, autologous BM re-
onstitution was investigated in mice treated with 5-FU at a
ose of 150 mg/kg. BM reconstitution was thus found to be
elayed in the MCMV persistently infected mice compared
ith the control animals even 21 days after 5-FU adminis-
ration (63.2% of the control; P , 0.05; Fig. 2). No plaque-
orming MCMV was detected in the serum, peripheral
lood cells, BM, spleen, liver, kidney, and lung in the mice
iven this dose of 5-FU (data not shown). It has been
eported that 5-FU treatment at this dosage spares the
rimitive HPCs and thus allows the autologous BM to
ecover (Van-Zant, 1984). Because we confirmed the iden-
ical number of phenotypically and functionally defined
PCs in control and MCMV persistently infected mice, the
elayed marrow reconstitution after 5-FU treatment ob-
erved in the MCMV persistently infected mice could be
scribed to the impairment of the supporting function of
ematopoiesis by hematopoietic ME.
upporting capacity of CFU-S formation in the MCMV
ersistently infected mice
To assess the functions of hematopoietic ME, either
he control mice or the MCMV persistently infected mice
ere used as recipients of CFU-S assay. The mice re-
eived lethal irradiation, by which no plaque-forming
CMV reappeared in the serum, peripheral blood cells,
M, spleen, liver, kidney, and lung (data not shown) and
FIG. 2. The effects of a persistent MCMV infection on the autologous
M recovery after 5-FU treatment. 5-FU (150 mg/kg) was injected
ntravenously into mice 4 weeks p.i. with 0.2 LD50 of MCMV. On days 4,
, 9, 14, and 21 after 5-FU treatment, BM cells were obtained from the
emurs and tibias, and then the total number was examined ([]). The
umber in the figure represents the number of BM cells (mean 6 SEM,
5 4). Uninfected mice were used as the control mice (f). *Significantceduction versus control (P , 0.05).hen received BM cells obtained from normal BALB/c
ice. The weights of the spleens were 83 6 5 mg in
ontrol mice and 78 6 6 mg in mice infected with MCMV,
hich did not show a significant difference. The number
f CFU-S on days 8 and 12 after the cell transfer were
ignificantly reduced in the MCMV persistently infected
ice compared with the control (P , 0.05; Fig. 3). These
esults indicated that a persistent MCMV infection could
mpair the capacity of CFU-S formation supported by ME.
lthough the splenic ME was assessed in the present
tudy, defects of splenic ME have been proposed to
eflect those of the BM ME (McCulloch et al., 1965).
hese findings strongly suggest that systemic hemato-
oietic ME could be impaired by a persistent MCMV
nfection.
ssessment of stromal cell function in vitro
We carried out another method to examine the hema-
opoietic ME, the LTBMC system, by using BM cells from
he control or MCMV persistently infected mice. This in
itro system is widely used to characterize the in vivo
ematopoietic ME (Dexter et al., 1977; Dorshkind 1990).
fter a confluent layer of heterogeneous adherent cells
as formed and the nonadherent cells were removed,
he culture was recharged with BM cells from normal
ice. We did not find any cytopathic effects of MCMV on
he adherent cells by light microscopy. The number of
onadherent cells and CFU-GM in LTBMC prepared from
he MCMV-infected mice rapidly decreased after re-
harging with the BM cells, whereas the number was
aintained at a high level in the LTBMC prepared from
FIG. 3. The effects of a persistent MCMV infection on the supporting
apacity of CFU-S formation. Mice 4 weeks p.i. with 0.2 LD50 of MCMV
ere lethally irradiated, and 1 3 105 BM cells from normal BALB/c mice
ere transferred. On days 8 and 12 after the transfer, the spleens were
emoved and the surface colonies were counted (p). The number in the
igure represents the number of CFU-S (mean 6 SEM, n 5 3 or 4).
ninfected mice were used as the control mice (u). *Significant reduc-
ion versus control (P , 0.05).ontrol mice (P , 0.05; Table 2). No such inhibitory
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148 MORI ET AL.ffects were observed in the mice inoculated with heat-
nactivated MCMV (data not shown). The presence of
FU-GM in adherent cells was also assessed to exclude
he possible contamination of CFU in adherent cells, and
o significant difference was observed between the con-
rol and MCMV-infected mice. These results suggest that
here thus could be defects in the hematopoietic ME of
he MCMV persistently infected mice, so it could not
upport the generation of HPCs and differentiating he-
atopoietic cells. Otherwise, such inhibitory effects
ould be due to the production of MCMV from adherent
ells in LTBMC.
etection of MCMV in BM cells
To elucidate the mechanism of the decreased ca-
acity of supporting hematopoiesis in the MCMV per-
istently infected mice, first, a PFU assay was per-
ormed to examine whether infectious virus is pro-
uced in the LTBMC, because infectious CMV has a
irect inhibitory effect on HPCs (Collier et al., 1989;
aciejewski et al., 1992; Sing et al., 1990). No virus
as detected by standard PFU assay in the superna-
ants of the LTBMC established from the MCMV-
nfected mice (data not shown). Recently, Kurz et al.
1997) developed an extremely sensitive assay that
ould detect infective virus as few as 2–9 viral ge-
omes and revealed the sensitivity of standard PFU
ssay was the equivalent of ;500 viral genomes. To
urther confirm the results of PFU assay, we examined
he expressions of the immediate-early-1 (IE) and gly-
oprotein B (gB) genes of MCMV, genes expressed in
he immediate-early and late phase of the virus repli-
ative cycle, respectively, by using RT-PCR. The ex-
ressions of these genes was not detected in BM
dherent cells (Fig. 4A). Based on these data, it was
nlikely that the virus produced due to reactivation in
TBMC exerted an inhibitory effect on HPCs. Second,
o examine the possible existence of MCMV DNA, a
T
Effects of a Persistent MCMV Infection on the Maintenanc
Total nonadherent cells/culture (3
4 7
ontrol 5.77 6 0.20 6.02 6 0.99
CMV 4 weeks p.i. 3.06 6 0.34a 2.37 6 0.53a
Note. A LTBMC was prepared from the BM cells of the control mice
ayer of adherent cells was formed and nonadherent cells were remov
, and 10 days after the recharge, viable nonadherent cells were counte
igure represents the mean 6 S.E.M.
a Significant reduction vs control (P , 0.05).CR to detect the specific DNA sequence of the IE aene of MCMV was performed using DNA extracted
rom the nonadherent and adherent cell fraction of the
TBMC. The MCMV IE gene was not detected in the
onadherent cells of the LTBMC; however, it was de-
ected in the adherent cells of the LTBMC (Fig. 4B).
aken together, these results strongly suggest that in
he MCMV persistently infected mice, MCMV latently
nfects the stromal cells of hematopoietic ME, which
ould contribute to the decreased capacity of ME to
upport hematopoiesis.
ffects of latent MCMV infection on the expressions
f cytokines and adhesion molecules
To identify the alterations in hematopoietic ME due to a
atent MCMV infection, the expression levels of the adhe-
ion molecules and several cytokines described under
aterials and Methods, which have a positive or nega-
ive effect on hematopoiesis (Mayer et al., 1997; Miyake
t al., 1991; Rusten et al., 1994; Simmons et al., 1992),
ere investigated using adherent cells from LTBMC by
low cytometry and RT-PCR. The MCMV infection had no
ignificant effect on the expressions of VCAM-1 and
CAM-1 by flow cytometry (data not shown). However, the
xpression of TNF-a was detected in the MCMV-infected
ice but not in the control mice, whereas the expression
f b-actin at the same time did not show difference
mong samples (Fig. 5). The expressions of other cyto-
ines, Flk-2/Flt-3 ligand (Flk-2), G-CSF, GM-CSF, interleu-
in (IL)-6, leukemia inhibitory factor (LIF), stem cell factor
SCF), thrombopoietin (TPO), and transforming growth
actor (TGF)-b, but not interferon (IFN)-g, were detected
y semiquantitative RT-PCR in both the MCMV-infected
nd control mice. These results thus suggest that the
ncreased expression of TNF-a by hematopoietic ME
ould in part inhibit hematopoiesis in the mice persis-
ently infected with MCMV because TNF-a is reported to
e a negative hematopoietic regulator (Broxmeyer et al.,
986; Jacobsen et al., 1994; Johnson et al., 1989; Zhang et
ematopoieitic Cells and CFU-GM Prodution in the LTBMC
Days cultured
Total CFU-GM/culture
0 4 7 10
7.62 1250 6 61 1114 6 102 4013 6 446
1.10a 502 6 36a 109 6 11a 60 6 22a
MV persistently infected (4 weeks p.i.) mice (n 5 4). After a confluent
culture was recharged with 1 3 107 BM cells from normal mice. At 4,
colony assays to detect CFU-GM were performed. The number in theABLE 2
e of H
106)
1
25.12 6
2.59 6
and MC
ed, the
d, andl., 1995).
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149BONE MARROW DYSFUNCTION IN MCMV INFECTIONDISCUSSION
It has been reported that CMV has a myelosuppres-
ive effect both in vivo and in vitro (Apperley et al., 1989;
ollier et al., 1989; Lagneauxet al., 1994; Maciejewski et
l., 1992; Simmons et al., 1990; Sing et al., 1990). How-
ver, the previous data from in vivo experiments are
ainly based on a primary infection using MCMV (Gib-
ons et al., 1995; Mori et al., 1997; Mutter et al., 1988).
urthermore, the persistent effects of HCMV are of clin-
cal importance, and a delayed platelet recovery after
MT has been reported in CMV-seropositive patients
Verdonck et al., 1991). Therefore, in the present study,
e examined the pathogenic effects of persistent MCMV
nfection on hematopoiesis.
Although we and other investigators have reported a
ecrease in the number of peripheral blood cells, BM
ells, and phenotypically and functionally defined HPCs
FIG. 4. Detection of MCMV DNA and RNA expressions. Nonadheren
weeks p.i. with 0.2 LD50 of MCMV. (A) RNA was extracted from the a
lands of a mouse acutely infected with MCMV was used as positive co
nd adherent cells, and MCMV-specific IE gene was amplified by PCR. T
onadherent and adherent cells from uninfected mice were used as an primary MCMV infection (Gibbons et al., 1995; Mori et Ml., 1997; Mutter et al., 1988), these parameters of con-
titutive hematopoiesis completely recovered to the con-
rol levels 4 weeks p.i. In contrast, marrow reconstitution
fter an injection of 5-FU was observed to be delayed in
he MCMV persistently infected mice, although no
laque-forming MCMV was detected in the serum, pe-
ipheral blood cells, BM, spleen, liver, kidney, and lung in
hese mice. We thus postulated that there could be some
mpairments in the hematopoietic ME, which thus could
ontribute to the decreased capacity of supporting in-
uctive hematopoiesis.
To characterize the hematopoietic ME in the MCMV
ersistently infected mice, we performed both a CFU-S
ssay, where control or MCMV-infected mice were used
s recipients, and the LTBMC system. The results from
oth experiments showed a decreased capacity to sup-
ort the proliferation and differentiation of HPCs in the
dherent cells were obtained from LTBMC, using BM cells from mice
t cells and used for RT-PCR of IE, gB, and b-actin. RNA from salivary
r IE and gB expression. (B) DNA was extracted from both nonadherent
leftmost lanes contained 1 and 10 pg of pAMB25 as a positive control.
ive control (N.C.).t and a
dheren
ntrol fo
he twoCMV persistently infected mice. In both experiments,
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150 MORI ET AL.he recurrence of MCMV from latency could complicate
he results because infectious MCMV directly inhibits the
roliferation and differentiation of HPCs (Collier et al.,
989; Maciejewski et al., 1992; Sing et al., 1990). How-
ver, plaque-forming MCMV was not detected either
fter lethal irradiation or in the LTBMC, and MCMV DNA
as not detected by PCR in the nonadherent cells in the
TBMC. This finding is compatible with a previous report
hat showed that the risk of MCMV recurrence from
atency is low after infection at an adult age (Reddehase
t al., 1994). It thus is plausible that an alteration in ME
ould be the cause of the decreased capacity of hema-
opoiesis observed in MCMV persistently infected mice.
FIG. 5. Detection of expressions of cytokines and b-actin in adherent
ells of LTBMC. Total RNA was obtained from the adherent cells of the
TBMC of unifected mice and mice 4 weeks p.i. with MCMV and
eat-inactivated MCMV. The specific cDNAs for cytokines and b-actin
ere amplified by PCR.It has been reported that BM and splenic stromal cells are the target of CMV infection both in vivo and in vitro,
hich results in the adverse effects on the growth and
roliferation of HPCs (Apperley et al., 1989; Pomeroy et
l., 1991; Simmons et al., 1990). In the present study, we
etected MCMV DNA in the adherent cells of LTBMC,
hich could represent stromal cells and macrophages,
y PCR. Recently, Mayer et al. (1997) reported that the
mount of infectious MCMV recovered from the BM was
ery low even in the acute phase of infection, whereas
oci of infection were detected in the BM stroma and the
ytokine expression was impaired. Neither IE nor gB
xpression was detected, although the viral genome was
resent in the BM stroma in the chronic phase of infec-
ion in this study. To further elucidate the mechanism by
hich ME is impaired by an MCMV-persistent infection,
e thus examined the expression of not only adhesion
olecules and cytokines, which have stimulatory effects
n hematopoiesis, but also cytokines, which suppress
ematopoiesis by stromal cells. Among all the cytokines
xamined, the expression of TNF-a by adherent cells
as significantly increased in the MCMV persistently
nfected mice, although RT-PCR allows only a semiquan-
itative determination of the mRNA levels. TNF-a is re-
orted to be a negative hematopoietic regulator (Brox-
eyer et al., 1986; Jacobsen et al., 1994; Johnson et al.,
989; Zhang et al., 1995), and a cytokine whose expres-
ion is induced by CMV (Duncombe et al., 1990; Geist et
l., 1994; Turtinen et al., 1989). It therefore is reasonable
o assume that the induced expression of TNF-a from
dherent cells may be at least one of the potent factors
hat inhibit hematopoiesis in MCMV persistently infected
ice. However, no inhibitory effect on colony formation
as observed in an in vitro colony assay when the
upernatants of LTBMC prepared from MCMV-infected
ice were added (data not shown). This result could be
xplained by either the role of the extracellular matrix of
tromal cells as a “humoral factor presenting network”,
amely, the essential trapping of soluble factors in ex-
racellular matrix to present them to HPCs (Campbell et
l., 1985; Grodon et al., 1987), or the membrane-bound
orm of TNF-a. Further study including the neutralization
f TNF-a by anti-TNF-a antibody is still necessary to
lucidate the exact role of TNF-a in ME. Although we did
ot detect the changes of the expression levels of the
ytokines other than TNF-a by semiquantitative RT-PCR,
e could not exclude the possible involvement of those
ytokines in the pathogenesis because this assay is not
ufficiently sensitive to detect the relative difference of
he gene expression. In particular, Mayer et al. (1997) and
teffen et al. (1998) reported that SCF gene expression
as impaired on day 14 after irradiation, BMT, and
CMV infection.
In the present study, we used the LTBMC system to
haracterize the stromal cells of hematopoietic ME. As
eported, the LTBMC is dependent on the heterogeneous
dherent cell layer, which consists of fibroblasts, adipo-
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151BONE MARROW DYSFUNCTION IN MCMV INFECTIONytes, endothelial cells, and macrophages (Dexter et al.,
977; Dorshkind 1990). The precise identification of the
ell type in adherent cell fractions that harbor MCMV and
redominantly express TNF-a is under investigation in
ur laboratory.
In conclusion, we demonstrated the possibility that
ematopoietic ME, but not HPCs, could play an important
ole in the inhibition of inductive hematopoiesis in MCMV
ersistently infected mice. The results presented here
ould have significant implications on the role of CMV
nfection in hematopoietic disorders, although further
tudies are required to apply these results in animal
odels to the impaired human hematopoiesis associ-
ted with HCMV.
MATERIALS AND METHODS
ice and virus inoculation
The female mice of an inbred BALB/c strain were
btained from Nippon Clea Inc. (Tokyo, Japan) and main-
ained in specific pathogen-free conditions. Ten- to 12-
eek-old mice were used for all experiments. All animals
ere handled in accordance with the guidelines estab-
ished by the Animal Experimentation Committee of To-
ai University School of Medicine. For some experi-
ents, 5-FU (Kyowa Hakko Kogyo Co., Tokyo, Japan) was
dministered through the tail vein at a dosage of 150
g/kg body weight. The Smith strain of MCMV (VR-194)
as originally obtained from the American Type Culture
ollection (Rockville, MD). The stock of MCMV used for
noculation was harvested from salivary gland tissue as
homogenate after being passed twice in BALB/c mice
nd was kept in a medium containing 0.1% dimethylsulf-
xide (Sigma, St. Louis, MO) at 280°C until use. For a
uantitative analysis of infectious MCMV, a plaque assay
as performed using a BALB-3T3 monolayer cell culture
s described previously (Jordan et al., 1983), and the
oncentration of the MCMV stock suspension was 8 3
07 PFU/ml. For infection, the mice were inoculated in-
raperitoneally with MCMV at a dose of 1 3 105 PFU
50.2 LD50). The homogenates of the salivary glands
rom the uninfected mice were used for inoculation into
he uninfected control mice (mock infection). Heat inac-
ivation of the virus was performed by incubating the viral
olution at 70°C for 15 min.
eripheral blood cell counts
Blood samples were obtained by an intracardiac punc-
ure and analyzed on Automated Hematology Analyzer
E8000 (Toa Medical Electronics Corp., Kobe, Japan) to
etermine the total leukocytes, erythrocyte parameters,
nd platelet numbers.
ollection and enumeration of BM cells
Suspensions of BM cells were obtained by flushing
he femurs and tibias with phosphate-buffered saline pPBS). The suspensions were passed through nylon
esh and then treated with NH4Cl to lyse the red blood
ells. The cells were resuspended with PBS, and the cell
iability was then assessed by trypan blue exclusion. All
amples showed .95% cell viability.
taining for cell surface markers and flow cytometry
nalysis
The population of HPCs was examined by flow cytom-
try as reported previously (Mori et al., 1997). Briefly, 2 3
06 cells were suspended with PBS containing 2% fetal
alf serum (FCS; GIBCO BRL, Grand Island, NY) and 0.1%
aN3, and then incubation for cell staining was carried
ut on ice for 30 min. As for the detection of lineage
arkers, rat monoclonal antibodies recognizing Mac-1
M1/70), Gr-1 (RB6–8C5), B220 (RA3–6B2), and an ery-
hroid marker (TER119) and FITC-conjugated monoclonal
ntibody for murine CD3 (145–2C11) were used. Antibod-
es for Mac-1, Gr-1, and B220 were purchased from
harMingen (San Diego, CA), and TER119 was kindly
rovided by Dr. Tatsuo Kina (Kyoto University, Kyoto,
apan). FITC-conjugated anti-rat IgG polyclonal antibody
Jackson ImmunoResearch Laboratories Inc., West
rove, PA) was used as a secondary antibody for the
etection of lineage markers. To assess the expressions
f c-kit and Sca-1, the cells were then further stained with
iotinylated anti-c-kit (2B8; PharMingen) and PE conju-
ated anti-Sca-1 antibodies (E13–161.7; PharMingen), fol-
owed by incubation with streptavidin-RED670 (GIBCO
RL). After the Lin2 population was gated, the expres-
ions of c-kit and Sca-1 were observed by detecting
ED670 and PE, respectively. To analyze the expressions
f SCF, VCAM-I, and ICAM-I on the adherent cells of
TBMC, confluent layers of adherent cells were treated
ith 1 mmol/L EDTA (GIBCO BRL) for 10 min and then
ashed twice with PBS. The cells were resuspended
ith PBS containing 2% FCS and 0.1% NaN3 and incu-
ated with anti-SCF (M3; Genzyme, Cambridge, MA),
CAM-I (429MVAM.A; PharMingen), and ICAM-I (3E2;
harMingen) antibody. Flow cytometry was performed
sing a FACScan (Becton Dickinson, Mountain View, CA)
quipped with three filters including a 530-nm band-pass
for FITC), a 585-nm band-pass (for PE), and a 650-nm
ong-pass filter (for RED670). The data were analyzed on
he LYSIS II program (Becton Dickinson).
n vitro colony assay
A CFU-GM and BFU-E assay was carried out in meth-
lcellulose culture using a METHOCULT M3430 kit (Stem
ell Technologies, Vancouver, Canada). Briefly, 1 ml of
ulture medium contained an appropriate number of BM
ells, 0.9% methylcellulose, 1% bovine serum albumin,
0% fetal bovine serum, 0.1 mM 2-mercaptoethanol, 2
M l-glutamine, 3 units of erythropoietin, and 2%okeweed mitogen-stimulated spleen cell-conditioned
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152 MORI ET AL.edium. The culture medium was prepared in a 35-mm
etri dish (Becton Dickinson) and incubated at 37°C in a
% CO2 atmosphere. The number of colonies was
ounted after 14 days of culture using an inverted micro-
cope.
FU-S assay
To determine the values of CFU-S in BM prepara-
ions, 1 3 105 BM cells obtained from mice were
ntravenously transferred into lethally irradiated (8.5
y) mice. On days 8 and 12 after the cell transfer, the
ice were killed, and their spleens were removed and
ixed in Bouin’s solution. The surface colonies of the
pleens, which each comprised the progeny of a sin-
le HPC, were counted. To rule out the possibility of
utologous colony formation after irradiation, the con-
rol mice were thus equally irradiated and received the
ame volume of PBS.
TBMC system
BM stromal cells were prepared by the modified meth-
ds of LTBMC.25 Briefly, 1 3 107 BM cells were cultured
n 10 ml of a-minimal essential medium (a-MEM) (GIBCO
RL) supplemented with 20% FCS, 500 units/ml penicil-
in, and 50 mg/ml streptomycin sulfate in a 25-cm2 cul-
ure flask (Iwaki Glass, Tokyo, Japan) at 33°C in a 5% CO2
tmosphere. At 4- to 6-day intervals, half of the medium
as replaced with fresh medium until a confluent layer of
dherent cells was formed. The nonadherent cells then
ere completely removed, and the culture was re-
harged with 1 3 107 BM cells from age-matched mice.
he number of HPC was assessed by colony assay with
he nonadherent cells at 3- to 4-day intervals after re-
harging.
etection of MCMV DNA by plaque-forming assay
nd PCR
For a quantitative analysis of infectious MCMV, a
laque assay was performed using a BALB-3T3 mono-
ayer cell culture as described previously (Jordan et al.,
983). To detect the MCMV DNA, a PCR analysis of the
CMV specific immediate-early (IE) gene was per-
ormed as described previously (Matsuzawa et al.,
995; Mori et al., 1997). Briefly, sample DNA was pre-
ared from the adherent and nonadherent cells of
TBMC by a series of phenol–chloroform extractions
nd ethanol purification. A pair of 24-bp oligonucleo-
ides, selected from exon 4 of the MCMV IE gene 1,
ere used as primers. Amplified DNA samples were
lectrophoresed on 1.2% agarose gel and then
restained with ethidium bromide for photography.
he gels were blotted onto a nylon membrane. A 24-bp
ligonucleotide, which was complementary to a se-
uence lying between the primers, was used as a
robe for Southern blot analysis and labeled by usinghe ECL 39-oligolabeling and Detection System (Amer-
ham, Buckinghamshire, U.K.). To compare the sensi-
ivity of PCR to the plaque assay, graded amounts of
iral stock solution were assayed by PCR. When a
50-bp region was amplified by the IE primer pair, the
nd point of the detectable amount was ;0.1 PFU.
emiquantitative analysis of cytokines and MCMV
xpression of stromal cells
Total RNA was prepared from adherent cells from
TBMC using a guideline of ISOGEN (Nippon Gene Co.,
oyama, Japan). Then, 1 mg of total RNA was reverse
ranscribed using oligo(dT) primer and RAV-2 reverse
ranscriptase (Takara, Otsu, Japan). Cytokine-specific
DNA were amplified by 30 cycles through 94°C for 1
in, 57°C for 2 min, and 72°C for 3 min in a TSR-300
hermal cycler (Iwaki Glass). b-Actin cDNA was amplified
y using primers as internal control at the same time as
ytokine cDNA was amplified. The cytokines examined
ere IL-6, Flk-2 ligand, LIF, SCF, G-CSF, GM-CSF, TP,
FN-g, TNF-a, and TGF-b. The primer sequences for the
ytokines have also been described previously (Allen et
l., 1993; McCarty et al., 1995; Szilvassy et al., 1996). For
he IE-1 gene of MCMV, the primers (forward/reverse)
nd the fragment length were 59-CCAGTTGCAACATGAT-
ATGATCGC-39/59-GCAGCATGCTTGATGGCCATGT-
GC-39 and 280 bp; for the gB gene of MCMV, the
rimers and the fragment length were 59-GTATCTCATCT-
CACGAGGC-39/59-GTACTCGAAATCGGAGTC-39 and
85 bp (Keil et al., 1987; Rapp et al., 1992).
tatistical analysis
A comparison of the mean values of the parameters
as done using the two-group paired t test.
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